Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acid-sensing ion channels (ASICs) are a family of voltage-insensitive, proton-gated cation channels that are primarily activated by extracellular acidification (a drop in pH). They are members of the degenerin/epithelial sodium channel (DEG/ENaC) superfamily and play critical roles in both physiological and pathophysiological processes, especially within the nervous system. They assemble as trimeric complexes composed of subunits with two transmembrane domains and a large extracellular loop. There are six main isoforms encoded by four genes: ASIC1a, ASIC1b, ASIC2a, ASIC2b, ASIC3, and ASIC4. ASICs are widely expressed throughout the central and peripheral nervous systems, as well as in non-neuronal tissues. They are involved in diverse processes including pain sensation, mechanotransduction, synaptic plasticity, and learning/memory. Dysregulation is implicated in conditions such as ischemic cell death, making them drug targets.
Inhibition of specific channel states
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acid-Sensing Ion Channel (ASIC).